Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994;46(1):29-33.
doi: 10.1007/BF00195912.

Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers

Affiliations
Clinical Trial

Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers

V Carrara et al. Eur J Clin Pharmacol. 1994.

Abstract

Since the magnitude of the response to a drug may depend upon the drug input rate, the concentration-effect relationship of the new dihydropyridine (+/-)-isradipine was investigated using different administration modalities. Ten normotensive healthy volunteers were given, double-blind and in a crossover fashion, isradipine as a 1 mg iv infusion, 5 mg oral solution, 5 mg standard tablet, 10 mg slow release formulation, and a placebo. Blood pressure, heart rate, and plasma isradipine concentrations were recorded for 24 h. The maximal fall in diastolic blood pressure was similar after the infusion (-11.40 mmHg), the oral solution (-15.20 mmHg), and the standard tablet (-12.50 mmHg). In healthy volunteers the slow release form had no significant effect on blood pressure. The concentration-effect plots showed an increasing slope in the order infusion, solution, and table, and anticlockwise hysteresis. This was partly due to marked heart rate counter-regulation, the corresponding mean maximal heart rate increases being 24, 19, and 17 beats.min-1. The pronounced counter-regulation of the heart rate implies that a slow isradipine input rate would be more effective in decreasing blood pressure.

PubMed Disclaimer

References

    1. AAPS J. 2011 Dec;13(4):662-4 - PubMed
    1. Circ Res. 1982 Mar;50(3):428-39 - PubMed
    1. J Clin Pharmacol. 1988 Jan;28(1):36-42 - PubMed
    1. Drugs. 1990 Jul;40(1):31-74 - PubMed
    1. Lancet. 1954 Feb 27;266(6809):429-33 - PubMed

LinkOut - more resources